Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;39(10):1038-1049.
doi: 10.1016/j.healun.2020.07.007. Epub 2020 Jul 23.

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-third pediatric lung transplantation report - 2020; focus on deceased donor characteristics

Affiliations
Review

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-third pediatric lung transplantation report - 2020; focus on deceased donor characteristics

Don Hayes Jr et al. J Heart Lung Transplant. 2020 Oct.
No abstract available

Keywords: lung transplantation; organ donor; outcomes; pediatric; survival.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Median donor (a) age (years), (b) BMI (kg/m2), and (c) PO2 (mm Hg) by year and geographic location (transplantations: January 1992–June 2018). BMI, body mass index; PO2, partial pressure of oxygen.
Figure 2
Figure 2
Donor sex distribution by geographic location and era (transplantations: January 1992–June 2018).
Figure 3
Figure 3
Donor cause of death distribution by geographic location and era (transplantations: January 1992–June 2018). CVA, cerebrovascular accident.
Figure 4
Figure 4
Percentage of donors with a history of (a) smoking and (b) alcohol use—for recipients aged 11–17 years and donors aged ≥11 years—by year (transplantations: January 2005–June 2018).
Figure 5
Figure 5
Kaplan–Meier survival within 12 months by donor age (transplantations: January 2000–June 2017). NS, non-significant.
Figure 6
Figure 6
Kaplan–Meier survival within 12 months by donor and recipient ages (transplantations: January 2000–June 2017). NS, non significant.
Figure 7
Figure 7
Kaplan–Meier survival within 12 months by donor age and geographic location (transplantations: January 2000–June 2017). NS, non-significant.
Figure 8
Figure 8
Kaplan–Meier survival within 12 months by (a) donor cause of death (transplants: January 2000–June 2017) and (b) donor PO2 (transplantations: January 2005–June 2017). CVA, cerebrovascular accident; NS, non-significant; PO2, partial pressure of oxygen.
Figure 9
Figure 9
Kaplan–Meier survival within 12 months for recipients aged 11—17 years and donors aged ≥11 years by donor history of smoking (transplantations: January 2000–June 2017). NS, nonsignificant.
Figure 10
Figure 10
Kaplan–Meier survival within 12 months by ischemic time (transplantations: January 2000–June 2017).
Figure 11
Figure 11
Kaplan–Meier survival within 12 months by ischemic time and donor age (transplantations: January 2000–June 2017). NS, non-significant.
Figure 12
Figure 12
Kaplan–Meier survival within 12 months by donor PO2 and ischemic time (transplantations: January 2005–June 2017). NS, non-significant; PO2, partial pressure of oxygen.
Figure 13
Figure 13
Kaplan–Meier survival within 5 years conditional on survival to 1 year by donor age (transplantations: January 2000–June 2013).
Figure 14
Figure 14
Kaplan–Meier survival within 5 years conditional on survival to 1 year by the recipient and donor ages (transplantations: January 2000–June 2013). NS, non-significant.
Figure 15
Figure 15
Kaplan–Meier survival within 5 years conditional on survival to 1 year by geographic location and donor age (transplantations: January 2000–June 2013). NS, non-significant. Note: There was no sufficient number of transplantations from donors 0 to 10 in other location.
Figure 16
Figure 16
Kaplan–Meier survival within 5 years conditional on survival to 1 year by (a) donor cause of death (transplantations: January 2000–June 2013) and (b) donor PO2 (transplantations: January 2005–June 2013). CVA, cerebrovascular accident; NS, non-significant; PO2, partial pressure of oxygen.
Figure 17
Figure 17
Kaplan–Meier survival within 5 years conditional on survival to 1 year by ischemic time (transplantations: January 2000–June 2013).
Figure 18
Figure 18
Kaplan–Meier survival within 5 years conditional on survival to 1 year by ischemic time and donor age (transplantations: January 2000–June 2013). NS, non-significant.
Figure 19
Figure 19
Freedom from BOS conditional on survival to discharge by donor age (transplantations: January 2000–June 2017). BOS, bronchiolitis obliterans syndrome; NS, non-significant.
Figure 20
Figure 20
Freedom from BOS conditional on survival to discharge by (a) donor cause of death (transplantations: January 2000–June 2017) and (b) donor PO2 (transplantations: January 2005–June 2017). BOS, bronchiolitis obliterans syndrome; CVA, cerebrovascular accident; NS, non-significant; PO2, partial pressure of oxygen.
Figure 21
Figure 21
Freedom from BOS conditional on survival to discharge by ischemic time (transplantations: January 2000–June 2017). BOS, bronchiolitis obliterans syndrome; NS, non-significant.

References

    1. Hayes D Jr, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019;38:1015–27. - PMC - PubMed
    1. Chambers DC, Cherikh WS, Harhay MO, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019;38:1042–55. - PMC - PubMed
    1. Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match [published correction appears in J Heart Lung Transplant 2020;39:91]. J Heart Lung Transplant 2019;38:1056–66. - PMC - PubMed
    1. Rossano JW, Singh TP, Cherikh WS, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric heart transplantation report - 2019; focus theme: donor and recipient size match. J Heart Lung Transplant 2019;38:1028–41. - PMC - PubMed
    1. Yusen RD, Edwards LB, Kucheryavaya AY, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report–2014; focus theme: retransplantation. J Heart Lung Transplant 2014;33: 1009–24. - PubMed

Publication types